SCHEMBL6804116

SCHEMBL6804116

Nc1cncn(C(C(=O)O)c2ccccc2)c1=O.[NaH]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
MAPK1 P28482 1/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.38
GABRA1 P14867 5/20 0.38
GABRB2 P47870 4/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ABCB11 O95342 1/20 0.38
GABRA2 P47869 1/20 0.38
GPBAR1 Q8TDU6 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
XIAP P98170 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805605 0.99 ALDH1A1 (0.44) ALDH1A1TDP1MAPK1LMNAGAA
Hydrochloric Acid SCHEMBL6805332 0.97 ALDH1A1 (0.43) ALDH1A1TDP1MAPK1LMNAGAA
SCHEMBL6804076 0.86 ALDH1A1 (0.36) ALDH1A1TDP1MAPK1LMNAGABRA1
SCHEMBL6802612 0.86 ALDH1A1 (0.33) ALDH1A1TDP1MAPK1CYP1A2CYP2C9
SCHEMBL6803008 0.86 GPBAR1 (0.40) ALDH1A1TDP1GPBAR1
SCHEMBL6810211 0.84 ALDH1A1 (0.36) ALDH1A1TDP1MAPK1LMNAGABRA1
SCHEMBL6805374 0.83 GPBAR1 (0.39) ALDH1A1MAPK1CYP1A2GPBAR1TSHR
SCHEMBL6804173 0.82 ALOX5 (0.43) GAACYP11B1CYP11B2L3MBTL1SMN1; SMN2
SCHEMBL6804327 0.82 CYP19A1 (0.39) ALDH1A1TDP1LMNAGAACYP3A4
SCHEMBL6905491 0.81 GABRA1 (0.40) ALDH1A1TDP1MAPK1LMNAGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063936-A1 Pyrimidine derivatives and process for preparing the same ONO PHARMACEUTICAL CO., LTD. (JP) 2004-04-01 US disclosed
EP-1346985-A1 PYRIMIDINE DERIVATIVES AND PROCESS FOR PREPARING THE SAME ONO PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063936-A1 Pyrimidine derivatives and process for preparing the same DPYD, NUDT1, UMPS ALDH1A1 134/4885TDP1 316/4885MAPK1 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.